Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal

项目摘要/摘要 伊利诺伊州芝加哥库克县医院(SHCC)的小约翰·H·斯特罗格是主要的三级医院 库克县卫生和医院系统(CCHHS)的护理网站。大多数癌症 病例来自少数族裔服务不足的人群，主要是非裔美国人。这个 SHCC MU NCORP计划继续加强和改善协调的护理和临床 通过参与NCTN计划为其少数民族人口进行研究。托马斯·E·拉德博士 将继续担任首席调查员(PI)。SCC MU-NCORP将继续促进 与现有癌症研究基地的关系，促进更广泛和更好的参与 乳腺癌、肺癌、前列腺癌、胃肠癌的控制、预防和护理服务研究 脑癌、血癌、头颈部癌和妇科癌症；促进- 为少数族裔服务不足的人群提供高质量的肿瘤学护理和新技术 社区，通过参与NCI批准的临床试验；侧重于预防、控制 和生存作为降低癌症发病率、发病率和死亡率的方法；鼓励 多学科癌症护理和地方一级的综合研究；参与癌症 与流程改进和临床试验相关的护理提供研究 通过协调库克县现有的基础设施特点开展实施活动 卫生与医院系统和县保健的管理保健社区网络；继续 为翻译研究项目提供带注释的组织和血液样本，例如 早期恶性肿瘤倡议和患者来源的异种移植计划；继续 通过主持ECOG小组范围内的癌症控制，在研究基地一级开展科学活动 关于女性癌症患者生殖问题的研究是构思、设计、 并由小肝癌MU NCORP发起；并增加对症状科学的参与 研究。

PROJECT SUMMARY/ABSTRACT John H. Stroger Jr, Hospital of Cook County (SHCC) in Chicago, Illinois is the major tertiary care site for the Cook County Health and Hospital System (CCHHS). The majority of cancer cases are from minority-underserved populations and are predominantly African American. The SHCC MU NCORP plans to continue to strengthen and improve coordinated care and clinical research for its minority population through participation in NCTN programs. Dr. Thomas E. Lad will continue as Principal Investigator (PI). The SHCC MU-NCORP will Continue to foster relationships with current cancer research bases to facilitate broad and improved participation in cancer control, prevention, and care delivery research for breast, lung, prostate, gastrointestinal, brain, hematologic, head and neck, and gynecologic cancers; facilitate transfer of state-of-the- are quality oncology care and new technology to minority-underserved populations in their own communities, through participation in NCI-approved clinical trials; focus on prevention, control and survivorship as methods for reducing cancer incidence, morbidity and mortality; encourage multidisciplinary cancer care and integrated research at the local level; participate in cancer care delivery research which accrue to trials relevant to process improvement and implementation activities by coordinating the existing infrastructural features of the Cook County Health & Hospitals System and CountyCare's Managed Care Community Network; continue to be a source of annotated tissue and blood samples for translational research projects such as the Early Onset Malignancy Initiative and the Patient Derived Xenograft project; continue scientific activity at the research base level by chairing an ECOG group-wide cancer control study concerning reproductive issues of female cancer patients that was conceived, designed, and initiated by the SHCC MU NCORP; and increase participation in symptom science research.